Japanese Society for Cutaneous Immunology and Allergy
Greeting from the President
Norito Katoh, President of JSCIA
Kyoto Prefectural University of Medicine
It is a great honor to be appointed president of The Japanese Society for Cutaneous Immunology and Allergy (JSCIA) in June, 2022. The JSCIA was established in 2017, after integration of three renown dermatological societies; The Antigen Investigating Society of Dermatology, The Dermatological Society for Patch Test, and The Dermatological Society for Vascular Diseases and Collagen Diseases. It covers a wide range of diseases such as contact dermatitis, atopic dermatitis, urticaria, drug eruption, occupational skin diseases, food allergy, and collagen diseases, and basic research on skin immunity and allergies.
Research on skin immunity and allergies has progressed dramatically, and the pathophysiology of many diseases has been elucidated in detail, and the results are directly linked to the development of treatments. With the changes in life and the widespread use of various products, allergies caused by new allergens may become a problem. Our Society will endeavor to contribute to society by exchanging the latest information on skin immune allergies and disseminating useful information not only to members but also to society.
We aim to contribute to the development of immunoallergic science by (1) educational activities such as hands-on seminars on skin tests for young doctors who will lead the future of skin immunoallergy and doctors who aim to become experts in skin immunoallergy (2) various activities in each specialized subcommittee including contact dermatitis, atopic dermatitis, urticaria/mast cells, drug eruption, food allergies, occupational allergies, collagen diseases/rheumatism and basic research (3) joint research across facilities and fields. It is also an important issue to further enhance and develop the Journal of Cutaneous Immunology and Allergy (JCIA), an official journal of JSCIA, which is a platform for transmitting and exchanging information globally. We will do our best with your cooperation.
We would like to contribute to the health and welfare of people through skin immunoallergology in collaboration with directors, representatives, members of various committees, and members. Thank you for your support and guidance.
